Información del producto
Nombre:Sodium 4-Aminophenylarsonate
Marca:Biosynth
Descripción:Sodium 4-aminophenylarsonate (APA) is a potential biomarker for the treatment of atherosclerosis. It is an enzyme that catalyzes the degradation of nonsteroidal anti-inflammatory drugs (NSAIDs). APA also has kinetic energy and can be used as a model system for studying mitochondrial membrane potential and locomotor activity.
Sodium 4-aminophenylarsonate (APA) is a potential biomarker for the treatment of atherosclerosis. It is an enzyme that catalyzes the degradation of nonsteroidal anti-inflammatory drugs (NSAIDs). APA also has kinetic energy and can be used as a model system for studying mitochondrial membrane potential and locomotor activity.
Sodium 4-aminophenylarsonate (APA) is a potential biomarker for the treatment of atherosclerosis. It is an enzyme that catalyzes the degradation of nonsteroidal anti-inflammatory drugs (NSAIDs). APA also has kinetic energy and can be used as a model system for studying mitochondrial membrane potential and locomotor activity.
Aviso:Nuestros productos están destinados únicamente para uso en laboratorio. Para cualquier otro uso, por favor contáctenos.
Propiedades químicas
Peso molecular:239.04 g/mol
Fórmula:C6H7AsNNaO3
Pureza:Min. 95%